Ludmila M. Savchenko

2/1 Barrikadnaya Street
Moscow, MOW 123995, Russian Federation

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 12 publications

CYP3A subfamily activity affects the equilibrium concentration of Phenazepam® in patients with anxiety disorders and comorbid alcohol use disorder.

CYP3A subfamily activity affects the equilibrium concentration of Phenazepam® in patients with anxiety disorders and comorbid alcohol use disorder.

Journal: Pharmacogenomics

Published: April 28, 2020

Evidence-based treatment of acute psychotic episode and schizophrenia in children and adolescents

Evidence-based treatment of acute psychotic episode and schizophrenia in children and adolescents

Journal: Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova

Published: January 30, 2020

Effects of CYP2C19*2 polymorphisms on the efficacy and safety of phenazepam in patients with anxiety disorder and comorbid alcohol use disorder.

Effects of CYP2C19*2 polymorphisms on the efficacy and safety of phenazepam in patients with anxiety disorder and comorbid alcohol use disorder.

Journal: Pharmacogenomics

Published: January 21, 2020

Effects of CYP2D6 genetic polymorphisms on the efficacy and safety of fluvoxamine in patients with depressive disorder and comorbid alcohol use disorder.

Effects of CYP2D6 genetic polymorphisms on the efficacy and safety of fluvoxamine in patients with depressive disorder and comorbid alcohol use disorder.

Journal: Pharmacogenomics and personalized medicine

Published: July 11, 2018

Effects of CYP2C19*17 polymorphisms on the efficacy and safety of bromodigyrochlorophenylbenzodiazepine in patients with anxiety disorder and comorbid alcohol use disorder.

Effects of CYP2C19*17 polymorphisms on the efficacy and safety of bromodigyrochlorophenylbenzodiazepine in patients with anxiety disorder and comorbid alcohol use disorder.

Journal: Drug metabolism and personalized therapy

Published: July 06, 2018

Using a personalized clinical decision support system for bromdihydrochlorphenylbenzodiazepine dosing in patients with anxiety disorders based on the pharmacogenomic markers.

Using a personalized clinical decision support system for bromdihydrochlorphenylbenzodiazepine dosing in patients with anxiety disorders based on the pharmacogenomic markers.

Journal: Human psychopharmacology

Published: June 22, 2018

The influence of CYP3A5 polymorphisms on haloperidol treatment in patients with alcohol addiction.

The influence of CYP3A5 polymorphisms on haloperidol treatment in patients with alcohol addiction.

Journal: Pharmacogenomics and personalized medicine

Published: January 19, 2018

Pharmacodynamic genetic polymorphisms affect adverse drug reactions of haloperidol in patients with alcohol-use disorder.

Pharmacodynamic genetic polymorphisms affect adverse drug reactions of haloperidol in patients with alcohol-use disorder.

Journal: Pharmacogenomics and personalized medicine

Published: July 27, 2017

Genotyping and phenotyping of CYP2D6 and CYP3A isoenzymes in patients with alcohol use disorder: correlation with haloperidol plasma concentration.

Genotyping and phenotyping of CYP2D6 and CYP3A isoenzymes in patients with alcohol use disorder: correlation with haloperidol plasma concentration.

Journal: Drug metabolism and personalized therapy

Published: June 13, 2017

The correlation between CYP2D6 isoenzyme activity and haloperidol efficacy and safety profile in patients with alcohol addiction during the exacerbation of the addiction.

The correlation between CYP2D6 isoenzyme activity and haloperidol efficacy and safety profile in patients with alcohol addiction during the exacerbation of the addiction.

Journal: Pharmacogenomics and personalized medicine

Published: October 04, 2016

EFFECT OF CARBAMAZEPINE ON THE ACTIVITY OF CYP3A4 ISOENZYME IN PATIENTS WITH ALCOHOL ADDICTION.

EFFECT OF CARBAMAZEPINE ON THE ACTIVITY OF CYP3A4 ISOENZYME IN PATIENTS WITH ALCOHOL ADDICTION.

Journal: Eksperimental'naia i klinicheskaia farmakologiia

Published: January 01, 2016

CYP3A4 activity and haloperidol effects in alcohol addicts.

CYP3A4 activity and haloperidol effects in alcohol addicts.

Journal: The International journal of risk & safety in medicine

Published: December 08, 2015

Showing 1-12 of 12

Last Updated: 09/26/2026